Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0755 Ast7062601
Novel AKAP1/PKA modulator, inducing UCP1 expression and thermogenesis
More description
DCC0754 Aß-in-10
Novel anti-Alzheimer’s agent, inhibiting amyloid β aggregation, β-secretase, and tau aggregation
More description
DCC0753 Aß/tau Probe 18
Novel near-infrared (NIR) probe for imaging β-amyloid (Aβ) plaques or Tau tangles
More description
DCC0752 Asr352
Novel potent anticancer agent, inhibiting the growth of CRC bulk and sensitized FOLFOX-resistant cells
More description
DCC0751 Aspulvinone H
Natural inhibitor of glutamic oxaloacetate transaminase 1 (GOT1), suppressing glutamine metabolism, making PDAC cells sensitive to oxidative stress and inhibiting cell proliferation, exhibiting potent in vivo antitumor activity in an SW1990-cell-induced x
More description
DCC0750 Aspulvinone E
Natural luciferase inhibitor
More description
DCC0749 Aspterric Acid
Natural inhibitor of pollen development in Arabidopsis thaliana, also inhibiting dihydroxy-acid dehydratase (DHAD)
More description
DCC0748 Asperphenamate
Natural antineoplastic agent, targeting cathepsin and inducing autophagy effects in breast cancer cells
More description
DCC0747 Asperlicin D
Novel cholecystokinin antagonist
More description
DCC0746 asperlicin C
Novel cholecystokinin antagonist
More description
DCC0745 asperlicin
Selective antagonist for the cholecystokinin receptor CCKA
More description
DCC0744 Asp9726
Novel potent Aspergillus hyphal growth inhibitor
More description
DCC0743 Asp9133
Novel long-acting muscarinic antagonist (LAMA), showing more selective inhibition of bronchoconstriction against salivation and more rapid onset of action than tiotropium bromide
More description
DCC0742 Asp-7962
Novel tropomyosin-related kinase A (TrkA) inhibitor for the oral treatment of pain due to osteoarthritis of the knee
More description
DCC0741 Asp5854
Novel dual A2A/A1 AR antagonist
More description
DCC0740 Asp2397
Novel antifungal agent against Aspergillus isolates
More description
DCC0739 Asoprisnil
Selective progesterone receptor modulator
More description
DCC0738 Asns-in-1
Novel slow-onset, tight binding, potent asparagine synthetase (ASNS) inhibitor
More description
DCC0737 Asn06917370
Novel potent GPR17 agonist
More description
DCC0736 Asn008
Novel Permanently-charged Sodium Channel Blocker, Showing Robust Efficacy, a Rapid Onset and Long Duration of Action
More description
DCC0735 Asm-in-21b
Novel, Potent, Selective, and Direct Acid Sphingomyelinase (ASM) Inhibitor with Antidepressant Activity
More description
DCC0734 Asm-024
Novel modulator of acetylcholine receptor function, promoting the in vitro relaxation of β2-adrenoreceptor desensitized tracheas
More description
DCC0733 Ask1 Inhibitor 32
Novel, Potent, Selective, and Brain-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Modulating Brain Inflammation In Vivo
More description
DCC0732 Ascochlorin
Natural Suppressor of MMP-2-Mediated Migration and Invasion by Targeting FAK and JAK-STAT Signaling Cascades
More description
DCC0731 Asc-082
Novel inhibitor of inositol-requiring enzyme 1 (IRE-1), also inhibiting G protein-coupled receptor kinase 6 (GRK6)
More description
DCC0730 Asah1-in-e2
Novel angiogenesis inhibitor, directly binding to acid ceramidase 1 (ASAH1)
More description
DCC0729 As-703569
Selective inhibitor of aurora kinases (AKs)
More description
DCC0728 As3334034
Novel Receptor-interacting Protein Kinase 2 (RIP2) Inhibitor
More description
DCC0727 As2034178
Novel GPR40 agonist
More description
DCC0726 As1938909
Novel SHIP2 inhibitor, increasing Akt phosphorylation, glucose consumption, and glucose uptake in L6 myotubes, specifically upregulating the GLUT1 gene
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X